Loading...
XJPX
6039
Market cap17mUSD
Jul 10, Last price  
1,062.00JPY
1D
0.76%
1Q
-27.95%
Jan 2017
-31.92%
IPO
-47.94%
Name

Japan Animal Referral Medical Center Co Ltd

Chart & Performance

D1W1MN
XJPX:6039 chart
P/E
3.49
P/S
0.47
EPS
304.72
Div Yield, %
0.70%
Shrs. gr., 5y
1.18%
Rev. gr., 5y
16.81%
Revenues
6.19b
+17.33%
002,093,414,0002,191,563,0002,258,890,0002,563,690,0002,734,051,0002,847,833,0002,979,011,0003,872,994,0004,270,194,9995,277,736,0006,192,468,000
Net income
833m
+59.97%
00214,817,000229,414,000208,092,000294,931,000312,818,000285,190,000286,939,000380,664,000337,217,000520,982,000833,428,000
CFO
1.40b
+1.71%
00431,832,000428,643,000344,407,000741,434,000537,979,000504,393,000557,574,000810,922,000899,782,0001,372,376,0001,395,827,000
Dividend
Mar 30, 20268 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized departments, from cardiology, respiratory, urology, and gastroenterology to oncology, neurology, orthopedics, ophthalmology, diagnostic imaging, and anesthesiology. Beyond direct patient care, the company also offers professional training, encompassing clinical instruction and treatment practices. Furthermore, it actively engages in research and development initiatives, exploring fields such as genetic testing, immunotherapy, and regenerative medicine. The firm, established in 2005, has its headquarters located in Kawasaki, Japan.
IPO date
Mar 26, 2015
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT